New Delhi: The Union Health Ministry on Monday dropped the use of ivermectin, hydroxychloroquine and anti-viral fevipiravir from the Kovid19 treatment guideline.
The nine-page guidelines released by the central government have widely used doctors to treat Kovid-19 patients across the country. Earlier guidelines issued by the Indian Council of Medical Research (ICMR) cited the use of ivermectin only in specific doses.
Experts have suggested that there is no scientific evidence that these drugs are effective against Kovid. Thus ivermectin, hydroxychloroquine, and anti-viral fevipiravir have been dropped from the Kovid therapy guideline. But it is emphasized that mask wear, physical distance and hands should be washed regularly in the guideline.
Remedy use of Remedicivir in the guideline. It is advised to use it only 10 days after the onset of the disease and if the condition worsens. In addition, guidelines for using tocilizumab, the prophylactic drug, are also mentioned in the guidelines. It is approved by the Drugs Controller General of India (DCGI).